Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro

Brain

Volumn 122, Issue 5, 1999, Pages 807-816

  Paparounas, Konstantinos ^a,b   O'Hanlon, Graham M ^a   O'Leary, Colin P ^a   Rowan, Edward G ^b   Willison, Hugh J ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Autoantibodies; Complement; Conduction block; Gangliosides; Peripheral neuropathy

Indexed keywords

CHOLERA TOXIN B SUBUNIT; COMPLEMENT; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; SAXITOXIN;

ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; ATAXIA; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ELECTROPHYSIOLOGY; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOHISTOLOGY; LATENT PERIOD; MALE; MOTOR NEUROPATHY; MOUSE; NERVE BLOCK; NERVE FUNCTION; NERVE POTENTIAL; NEUROPHYSIOLOGY; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; RANVIER NODE; SCIATIC NERVE; SUBCLAVIAN STEAL SYNDROME;

EID: 0032922531     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.5.807     Document Type: Article

References (45)

1. Arasaki K, Kusunoki S, Kudo N, Kanazawa I. Acute conduction block in vitro following exposure to antiganglioside sera. Muscle Nerve 1993; 16: 587-93.
2. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antidody is associated with ophthalmoplegia in Miller-Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 1993; 43: 1911-7.
3. Dempster J. Computer analysis of electrophysiological signals. In: Frazer PJ, editor. Microcomputers in physiology: a practical approach. Oxford: IRL Press; 1988. p. 51-93.
4. Freddo L, Yu RK, Latov N, Donofrio PD, Hays AP, Greenberg HS, et al. Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease. Neurology 1986; 36: 454-8.
5. Fross RD, Daube JR. Neuropathy in the Miller-Fisher syndrome: clinical and electrophysiologic findings. Neurology 1987; 37: 1493-8.
6. Gregson NA, Jones D, Thomas PK, Willison HJ. Acute motor neuropathy with antibodies to GM1 ganglioside. J Neurol 1991; 238: 447-51.
7. Harvey GK, Toyka KV, Zielasek J, Kiefer R, Simonis C, Hartung HP. Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer. Muscle Nerve 1995; 18: 388-94.
8. Hirota N, Kaji R, Bostock H, Shindo K, Kawasaki T, Mizutani K, et al. The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons. Brain 1997; 120: 2159-69.
9. Holmgren J. Actions of cholera toxin and the prevention and treatment of cholera. [Review]. Nature 1981; 292: 413-7.
10. Hubbard JI, Jones SF, Landau EM, An examination of the effects of osmotic pressure changes upon transmitter release from mammalian motor nerve terminals. J Physiol (Lond) 1968; 197: 639-57.
11. Ilyas AA, Willison HJ, Quarles RH, Jungalwala FB, Cornblath DR, Trapp BD, et al. Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann Neurol 1988; 23: 440-7.
12. Kornberg AJ, Pestronk A. Chronic motor neuropathies: diagnosis, therapy, and pathogenesis. [Review]. Ann Neurol 1995; 37 Suppl 1: S43-50.
13. Kusunoki S, Shimizu J, Chiba A, Ugawa Y, Hitoshi S, Kanazawa I. Experimental sensory neuropathy induced by sensitization with ganglioside GDIb. Ann Neurol 1996; 39: 424-31.
14. Kusunoki S, Mashiko H, Mochizuki N, Chiba A, Arita M, Hitoshi S, et al. Binding of antibodies against GM1 and GD1b in human peripheral nerve. Muscle Nerve 1997; 20: 840-5.
15. Ledeen R. Gangliosides of the neuron. Trends in Neurosci 1985; 8: 169-74.
16. McFarlin DE. Immunological parameters in Guillain-Barré syndrome. [Review]. Ann Neurol 1990; 27 Suppl: S25-9.
17. Molander M, Berthold CH, Persson H, Andersson K, Fredman P. Monosialoganglioside (GM1) immunofluorescence in rat spinal roots studied with a monoclonal antibody. J Neurocytol 1997; 26: 101-11.
18. O'Hanlon GM, Paterson GJ, Wilson G, Doyle D, McHardie P, Willison HJ. Anti-GM1 ganglioside antibodies cloned from autoimmune neuropathy patients show diverse binding patterns in the rodent nervous system. J Neuropathol Exp Neurol 1996; 55: 184-95.
19. O'Hanlon GM, Paterson GJ, Veitch J, Wilson G, Willison HJ. Mapping immunoreactive epitopes in the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodies. Acta Neuropathol. In press 1998.
20. Paterson G, Wilson G, Kennedy PG, Willison HJ. Analysis of anti-GM1 ganglioside IgM antibodies cloned from motor neuropathy patients demonstrates diverse V-region gene usage with extensive somatic mutation. J Immunol 1995; 155: 3049-59.
21. Pestronk A. Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies. [Review]. Muscle Nerve 1991; 14: 927-36.
22. Pestronk A, Cornblath DR, Ilyas AA, Baba H, Quarles RH, Griffin JW, et al. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 1988; 24: 73-8.
23. Pestronk A, Chaudhry V, Feldman EL, Griffin JW, Cornblath DR, Denys EH, et al. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies. Ann Neurol 1990; 27: 316-26.
24. Plomp JJ, Molenaar PC, O'Hanlon GM, Jacobs BC, Veitch J, Daha MR, et al. Miller-Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates. Ann Neurol 1999; 45: 189-99.
25. Roberts M, Willison H, Vincent A, Newsom-Davis J. Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release [see comments]. Lancet 1994; 343: 454-5. Comment in: Lancet 1994; 343: 1290.
26. Roberts M, Willison H, Vincent A, Newsom-Davis J. Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release [see comments]. Lancet 1994; 343: 454-5. Comment in: Lancet 1994; 343: 1290.
27. Ropper AH. The Guillain-Barré syndrome. [Review]. N Engl J Med 1992; 326: 1130-6.
28. Santoro M, Thomas FP, Fink ME, Lange DJ, Uncini A, Wadia NH, et al. IgM deposits at the nodes of Ranvier in a patient with amyotrophic lateral sclerosis, anti-GM1 antibodies, and multifocal motor conduction block [see comments]. Ann Neurol 1990; 28: 373-7. Comment in: Ann Neurol 1991; 30: 225-7.
29. Santoro M, Thomas FP, Fink ME, Lange DJ, Uncini A, Wadia NH, et al. IgM deposits at the nodes of Ranvier in a patient with amyotrophic lateral sclerosis, anti-GM1 antibodies, and multifocal motor conduction block [see comments]. Ann Neurol 1990; 28: 373-7. Comment in: Ann Neurol 1991; 30: 225-7.
30. Santoro M, Uncini A, Corbo M, Staugaitis SM, Thomas FP, Hays AP, et al. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann Neurol 1992; 31: 385-90.
31. Svennerholm L. Designation and schematic structure of gangliosides and allied glycoshingolipids. Prog in Brain Res 1994; 101: XI-XIV.
32. + currents in isolated rat myelinated nerve fibers [see comments]. Ann Neurol 1995; 37: 436-42. Comment in: Ann Neurol 1995; 37: 421-3.
33. + currents in isolated rat myelinated nerve fibers [see comments]. Ann Neurol 1995; 37: 436-42. Comment in: Ann Neurol 1995; 37: 421-3.
34. Thomas PD, Brewer GJ. Gangliosides and synaptic transmission. [Review]. Biochim Biophys Acta 1990; 1031: 277-89.
35. Uncini A, Santoro M, Corbo M, Lugaresi A, Latov N. Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies. Muscle Nerve 1993; 16: 610-5.
36. Willison HJ. Antiglycolipid antibodies in peripheral neuropathy: fact or fiction? [editorial]. [Review]. J Neurol Neurosurg Psychiatry 1994; 57: 1303-7.
37. Willison HJ, Kennedy PG. Gangliosides and bacterial toxins in Guillain-Barré syndrome. [Review]. J Neuroimmunol 1993; 46: 105-12.
38. Willison HJ, Veitch J, Paterson G, Kennedy PG. Miller-Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry 1993a; 56: 204-6.
39. Willison HJ, Paterson G, Veitch J, Inglis G, Barnett SC. Peripheral neuropathy associated with monoclonal IgM anti-Pr2 cold agglutinins. J Neurol Neurosurg Psychiatry 1993b; 56: 1178-83.
40. Willison HJ, O'Hanlon GM, Paterson GJ, Veitch J, Wilson G, Roberts M, et al. A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18 [see comments]. J Clin Invest 1996; 97:1155-64. Comment in: J Clin Invest 1996; 97: 1136-7.
41. Willison HJ, O'Hanlon GM, Paterson GJ, Veitch J, Wilson G, Roberts M, et al. A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18 [see comments]. J Clin Invest 1996; 97:1155-64. Comment in: J Clin Invest 1996; 97: 1136-7.
42. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis [see comments]. Neurology 1990; 40: 1900-2. Comment in Neurology 1991; 41: 1327-8, Comment in: Neurology 1991; 41: 1530-1, Comment in: Neurology 1993; 43: 1443-4.
43. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis [see comments]. Neurology 1990; 40: 1900-2. Comment in Neurology 1991; 41: 1327-8, Comment in: Neurology 1991; 41: 1530-1, Comment in: Neurology 1993; 43: 1443-4.
44. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis [see comments]. Neurology 1990; 40: 1900-2. Comment in Neurology 1991; 41: 1327-8, Comment in: Neurology 1991; 41: 1530-1, Comment in: Neurology 1993; 43: 1443-4.
45. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis [see comments]. Neurology 1990; 40: 1900-2. Comment in Neurology 1991; 41: 1327-8, Comment in: Neurology 1991; 41: 1530-1, Comment in: Neurology 1993; 43: 1443-4.